Publications & Presentations
November 14, 2017
From Inside Health Policy

Hospitals Look To Tie Moratorium On 340B Drug Reimbursement Cuts To Must-Pass Legislation

by Michelle M. Stein

House GOP lawmakers are expected to spearhead a bipartisan bill to block pay cuts for 340B drugs that may be introduced as early as this week, a hospital lobbyist said. Hospital lobbyists want to include a moratorium on cuts to reimbursement for 340B drugs in must-pass legislation before the end of the year. However, those following the issue caution that it would be tough to get a legislative fix through both chambers before the cuts take effect.
Julius Hobson, senior policy adviser at Polsinelli, said hospitals' best bet is try to get lawmakers to attach such a policy to a year-end package, but it could be tough. The House Energy & Commerce Committee has been critical of the 340B program; Chair Greg Walden (R-OR) recently raised concerns with the program's growth and lack of clear data on what hospitals do with the money they earn from discounts. Also, after the cut was proposed, a senior House Republican staffer said lawmakers are paying more attention to the Health Resources and Services Administration's authority over 340B than on CMS' policy.
Subscribers can view the full article here.